22249-Lymphomas-NA-22

Lymphomas

First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants with B-cell Malignancies (M23-647)

  • Details

ClinicalTrials.gov ID: NCT05753501
Diagnosis Type: NA
USOR Number:

  • Address

1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7659

Search by practice name, trial titles, indicators and specific disease types.